A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC.

MLA

Bullock, Kennady K., et al. “A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC.” Cancers, vol. 16, no. 23, Dec. 2024, p. 4075. EBSCOhost, https://doi.org/10.3390/cancers16234075.

APA

Bullock, K. K., Hasaka, T., Days, E., Bauer, J. A., Ward, P. A., & Richmond, A. (2024). A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC. Cancers, 16(23), 4075. https://doi.org/10.3390/cancers16234075

Chicago

Bullock, Kennady K., Thomas Hasaka, Emily Days, Joshua A. Bauer, Patricia A. Ward, and Ann Richmond. 2024. “A High-Throughput Immune-Oncology Screen Identifies Immunostimulatory Properties of Cytotoxic Chemotherapy Agents in TNBC.” Cancers 16 (23): 4075. doi:10.3390/cancers16234075.